Wuxi Apptec Co Ltd.(WUXAY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

WUXAY Wuxi Apptec Co Ltd.

已收盘 01-21 16:00:00 EST 延时

{"stockData":{"symbol":"WUXAY","market":"US","secType":"STK","nameCN":"Wuxi Apptec Co Ltd.","latestPrice":14.62,"timestamp":1769029200000,"preClose":14.5,"halted":0,"volume":1006,"delay":15,"changeRate":0.008275862068965464,"floatShares":2952000000,"shares":2952000000,"eps":0.446861,"marketStatus":"已收盘","change":0.12,"latestTime":"01-21 16:00:00 EST 延时","open":14.56,"high":14.62,"low":14.56,"amount":14684.980000000001,"amplitude":0.004138,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.446861,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1769072400000},"marketStatusCode":5,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":14.5,"volumeRatio":0.765718},"requestUrl":"/m/hq/s/WUXAY","defaultTab":"news","newsList":[{"id":"2503587276","title":"药明康德正式加入制药供应链倡议（PSCI）","url":"https://stock-news.laohu8.com/highlight/detail?id=2503587276","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503587276?lang=zh_cn&edition=full","pubTime":"2025-01-13 08:00","pubTimestamp":1736726400,"startTime":"0","endTime":"0","summary":"上海2025年1月13日 /美通社/ -- 药明康德近日宣布，公司正式加入制药供应链倡议，成为PSCI供应商合作伙伴。成为供应商合作伙伴意味着与PSCI携手，致力于在安全、环境和社会效益等方面获得卓越表现，为全球制药和医疗健康价值链建设做出积极贡献。药明康德出色的ESG表现也受到了CDP、ISS等全球ESG评级机构的高度认可。2024年，药明康德连续第四年被MSCI评为ESGAA级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4594261_ZH94261_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["PSCI","LU0708995583.HKD","BK1576","603259","LU1997245177.USD","LU1997245094.SGD","BK0216","BK1583","LU1046422090.SGD","LU2045819591.USD","02359","LU2488822045.USD","LU0320764599.SGD","LU0052750758.USD","LU2242644610.SGD","BK4121","LU2125910500.SGD","BK1141","WUXAY","LU0456842615.SGD"],"gpt_icon":0},{"id":"2495545795","title":"药明康德连续四年入选道琼斯可持续发展指数（DJSI）","url":"https://stock-news.laohu8.com/highlight/detail?id=2495545795","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495545795?lang=zh_cn&edition=full","pubTime":"2024-12-30 20:00","pubTimestamp":1735560000,"startTime":"0","endTime":"0","summary":"上海2024年12月30日 /美通社/ -- 药明康德近日宣布公司入选2024年道琼斯可持续发展世界指数和新兴市场指数，这也是药明康德第四年入选道琼斯可持续发展指数，充分彰显了公司对推动可持续发展和践行负责任商业实践的坚定承诺。\"很荣幸药明康德因在可持续发展和赋能创新方面的杰出表现，获得道琼斯可持续发展指数的认可，并再次同时入选道琼斯可持续发展世界指数和新兴市场指数。2024年，药明康德连续第四年被MSCI评为ESGAA级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4586832_ZH86832_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["DXD","603259","UDOW","BK1583","DJX","LU2125910500.SGD","LU1997245177.USD","LU2488822045.USD","BK1576","LU0320764599.SGD","LU2045819591.USD","LU2242644610.SGD","02359","DOG","LU0708995583.HKD",".DJI","LU0456842615.SGD","BK0216","LU1046422090.SGD","WUXAY","SDOW","BK4121","LU0052750758.USD","LU1997245094.SGD","BK1141","DDM"],"gpt_icon":0},{"id":"2485362485","title":"药明康德获2024年EcoVadis企业社会责任评级\"金牌\"认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2485362485","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485362485?lang=zh_cn&edition=full","pubTime":"2024-11-21 08:00","pubTimestamp":1732147200,"startTime":"0","endTime":"0","summary":"上海2024年11月21日 /美通社/ -- 药明康德近日宣布，公司在2024年EcoVadis企业社会责任评级中获得金牌认证，位列所有参评公司前2%。这一评级不仅彰显了药明康德对可持续发展的坚定承诺，也体现了公司将环境及社会责任融入战略规划和业务运营的不懈努力。EcoVadis作为全球知名的企业社会责任和可持续发展评估平台，是全球企业衡量和提升业务和价值链可持续发展表现的重要参考指标。2024年，药明康德连续第四年被MSCI评为ESGAA级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4561900_ZH61900_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02359","WUXAY","603259"],"gpt_icon":0},{"id":"2482791881","title":"行业第一，药明康德在2024年标普全球企业可持续发展评估中获\"生命科学工具与服务\"领域最高分","url":"https://stock-news.laohu8.com/highlight/detail?id=2482791881","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482791881?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:00","pubTimestamp":1731369600,"startTime":"0","endTime":"0","summary":"上海2024年11月12日 /美通社/ -- 药明康德近日宣布，公司在2024年标普全球企业可持续发展评估中获得行业最高分，位列全球\"生命科学工具与服务\"领域第一[1]。在2024年CSA评估中，药明康德获得了80分的优异成绩，相较2023年提升了11分。药明康德出色的ESG表现也受到了CDP和EcoVadis等全球ESG评级机构的高度认可。2024年，药明康德连续第四年被MSCI评为ESGAA级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4552900_ZH52900_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1989763005.USD","WUXAY","LU1989772840.SGD","LU1363072403.SGD","IE00B19Z9505.USD","LU2210150020.SGD","LU0354030511.USD","LU0052750758.USD","SG9999014898.SGD","LU1997245094.SGD","02359","603259","BK1576","SG9999017495.SGD","LU1988902786.USD","LU1064131342.USD","LU0158827948.USD","BK4121","BK4548","SG9999018857.SGD","LU1989772923.USD","LU1989764664.SGD","LU2271345857.HKD","SGXZ31699556.SGD","LU1989764748.USD","BK4585","LU0158827781.USD","LU2045819591.USD","LU0320764599.SGD","LU0342679015.USD","SPGI","LU0097036916.USD","LU1046422090.SGD","LU0985320562.USD","LU1997245177.USD","LU0345774391.USD","LU2028103732.USD","LU2265009873.SGD","BK4566","BK1583","BK4112","LU0868494617.USD","LU1989773731.SGD","BK4588","LU0354030438.USD","GB00BDT5M118.USD","LU2095319765.USD","LU1633808545.USD","LU0971096721.USD","LU2089283258.USD"],"gpt_icon":0},{"id":"2479933362","title":"药明康德连续八年荣膺弗若斯特沙利文\"全球CRDMO年度公司奖\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2479933362","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479933362?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:00","pubTimestamp":1730246400,"startTime":"0","endTime":"0","summary":"上海2024年10月30日 /美通社/ -- 近日，全球增长咨询公司弗若斯特沙利文公布了2024年度\"最佳实践奖\"评选结果，药明康德凭借行业领先的一体化、端到端新药研发及生产赋能平台，荣获\"2024全球CRDMO年度公司奖\"。这是药明康德连续第八年获得该机构的认可。\"我们很荣幸获得2024全球CRDMO年度公司奖。2024年，药明康德连续第四年被MSCI评为ESGAA级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4542792_ZH42792_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2488822045.USD","02359","LU1997245177.USD","BK1576","LU0456842615.SGD","LU2125910500.SGD","LU2242644610.SGD","LU1997245094.SGD","BK4121","BK1583","WUXAY","LU0708995583.HKD","LU1046422090.SGD","603259","LU0052750758.USD","BK1141","LU0320764599.SGD","BK0216","LU2045819591.USD"],"gpt_icon":0},{"id":"2478810923","title":"在外部环境挑战下，药明康德2024年前三季度收入和利润环比持续提升；第三季度收入重回百亿规模，剔除新冠商业化项目同比增长14.6%；在手订单同比增长35.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478810923","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478810923?lang=zh_cn&edition=full","pubTime":"2024-10-28 19:04","pubTimestamp":1730113440,"startTime":"0","endTime":"0","summary":"截至2024年9月底，公司在手订单438.2亿元，同比增长35.2%。前三季度，来自于全球前20大制药企业收入达到人民币112.2亿元，剔除新冠商业化项目同比增长23.1%。管理层评论 药明康德董事长兼首席执行官李革博士表示：\"在外部环境挑战下，公司2024年前三季度收入及利润按计划环比稳步提升；第三季度收入重回百亿规模，剔除新冠商业化项目同比增长14.6%，同时在手订单实现人民币438.2亿，同比增长35.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4541331_ZH41331_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4505","LU0456842615.SGD","BK4139","LU2488822045.USD","WUXAY","LU0708995583.HKD","LU2045819591.USD","TIL","LU0052750758.USD","LU1046422090.SGD","02359","BK4121","BK0216","BK1576","BK1141","LU0320764599.SGD","LU1997245094.SGD","BK1583","603259","LU1997245177.USD","LU2125910500.SGD","LU2242644610.SGD"],"gpt_icon":0}],"profile":{"exchange":"PINK LIMITED","name":"Wuxi Apptec Co Ltd.","nameEN":"Wuxi Apptec Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Wuxi Apptec Co Ltd.(WUXAY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Wuxi Apptec Co Ltd.(WUXAY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Wuxi Apptec Co Ltd.,WUXAY,Wuxi Apptec Co Ltd.股票,Wuxi Apptec Co Ltd.股票老虎,Wuxi Apptec Co Ltd.股票老虎国际,Wuxi Apptec Co Ltd.行情,Wuxi Apptec Co Ltd.股票行情,Wuxi Apptec Co Ltd.股价,Wuxi Apptec Co Ltd.股市,Wuxi Apptec Co Ltd.股票价格,Wuxi Apptec Co Ltd.股票交易,Wuxi Apptec Co Ltd.股票购买,Wuxi Apptec Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Wuxi Apptec Co Ltd.(WUXAY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Wuxi Apptec Co Ltd.(WUXAY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}